Researchers warn early encouraging signals from small-scale preliminary trials for the use of hydroxychloroquine to treat coronavirus should be taken with caution. Current evidence suggests chloroquine and hydroxychloroquine can not be used as a general treatment for all COVID-19 infections. Researchers say the medications should be restricted for the treatment of COVID-19 patients with pneumonia and high death risk, and only then as part of a clinical trial. The study also points out the negative side effects produced by the anti-malarial drugs and warns that those who need the medication to treat Lupus might not have access to treatment if widespread use for coronavirus occurs. The study reports there is no evidence to support the mass use of chloroquine or hydroxychloroquine to prevent infection from occurring.
Researchers answer the questions of whether artificial intelligence is better at facial recognization than humans. The study found both humans and deep learning algorithms perform with similar levels of accuracy when identifying faces. However, when AI technology is combined with human intelligence, the accuracy attainment levels shot up and better results were achieved than when two facial examiners worked together.
A new study reveals, contrary to popular belief, children with ASD are able to create imaginary companions. Imaginary friends, researchers argue, are an important feature in a child's emotional development.
Researchers have developed a new method for testing for multiple sclerosis. Using blood samples, researchers look for lower concentrations of sphingosine and dihydrosphingosine, two compounds linked to the neurodegnerative disease.